Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, D. I.
Right arrow Articles by Goldhammer, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, D. I.
Right arrow Articles by Goldhammer, Y.
Related Collections
Right arrow Idiopathic intracranial hypertension
Right arrow Secondary headache disorders
Right arrow All Neuro-ophthalmology
Right arrow Optic nerve
NEUROLOGY 2004;62:2297-2299
© 2004 American Academy of Neurology


Brief Communications

Doxycycline and intracranial hypertension

D. I. Friedman, MD, L. K. Gordon, MD PhD, R. A. Egan, MD, D. M. Jacobson, MD{dagger}, H. Pomeranz, MD PhD, A. R. Harrison, MD and Y. Goldhammer, MD

From the Departments of Ophthalmology and Neurology (Dr. Friedman), University of Rochester School of Medicine and Dentistry, NY, Jules Stein Eye Institute (Dr. Gordon), David Geffen School of Medicine, University of California at Los Angeles, and Greater Los Angeles Veterans Administration Healthcare System, Casey Eye Institute (Dr. Egan), Departments of Ophthalmology and Neurology, Oregon Health and Science University, Portland, Department of Neurology (Dr. Jacobson), Marshfield Clinic, WI, Department of Ophthalmology (Drs. Pomeranz and Harrison), University of Minnesota, Minneapolis; and Department of Neurology (Dr. Goldhammer), Sheba Medical Center, Tel-Hashomer, Israel.

Address correspondence and reprint requests to Dr. D.I. Friedman, Department of Ophthalmology, University of Rochester, 601 Elmwood Ave., Box 659, Rochester, NY 14642; e-mail: Deborah_Friedman{at}urmc.rochester.edu

The authors report seven patients from six neuro-ophthalmology referral centers who developed pseudo-tumor cerebri during treatment with doxycycline. All four female patients and one of three male patients were obese. Vision was minimally affected in most patients, but two had substantial visual acuity or visual field loss at presentation. Discontinuation of doxycycline, with or without additional intracranial pressure-lowering agents, yielded improvement, but permanent visual acuity or visual field loss occurred in five patients.


Received October 8, 2003. Accepted in final form February 23, 2004.

{dagger}Deceased.




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
B. J. Winn, Y. J. Liao, and J. C. Horton
Intracranial Pressure Returns to Normal About a Month After Stopping Tetracycline Antibiotics
Arch Ophthalmol, August 1, 2007; 125(8): 1137 - 1138.
[Full Text] [PDF]


Home page
NeurologyHome page
A. Y. K. Chan, D. T. L. Liu, D. I. Friedman, L. K. Gordon, and R. A. Egan
Doxycycline and intracranial hypertension
Neurology, February 22, 2005; 64(4): 765 - 766.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Doxycycline and intracranial hypertension
Alice Y.K. Chan, et al.
Neurology Online, 27 Sep 2004 [Full text]
Reply to Chan et al
Deborah I Friedman, et al.
Neurology Online, 27 Sep 2004 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.